Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA.

Vicente Plaza Moral Javier Dominguez-OrtegaDiego González-Segura AlsinaDaniele Lo ReAntoni Sicras-Mainar

Published in: Pharmaceuticals (Basel, Switzerland) (2023)

TT reduced asthma exacerbations, improved lung function and reduced healthcare costs vs. DT, particularly in patients requiring systemic corticosteroids to treat severe exacerbations.

Keyphrases

lung function
chronic obstructive pulmonary disease
end stage renal disease
cystic fibrosis
healthcare
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
early onset
health information
muscular dystrophy